Ambee Pharmaceuticals (DHA:AMBEEPHA) Research & Development: BDT Mil (TTM As of . 20)


DHA:AMBEEPHA Ambee Pharmaceuticals Plc DHA:AMBEEPHA
18 GF Score
Price BDT754.00
View Full Analysis

What is Ambee Pharmaceuticals Research & Development?

Ambee Pharmaceuticals DHA:AMBEEPHA -0.33% 18 Research & Development is BDT Mil as of . 20. GuruFocus rates DHA:AMBEEPHA with a GF Score™ of 18/100.

Research & Development is the aggregate amount of research and development expenses during the year. Ambee Pharmaceuticals's Research & Development for the six months ended in . 20 was BDT0.00 Mil. Ambee Pharmaceuticals does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.

Ambee Pharmaceuticals  (DHA:AMBEEPHA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ambee Pharmaceuticals Research & Development Related Terms

Ambee Pharmaceuticals Research & Development Historical Data

* Premium members only.

The historical data trend for Ambee Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambee Pharmaceuticals Research & Development Chart

Ambee Pharmaceuticals Annual Data
Trend
Research & Development

Ambee Pharmaceuticals Semi-Annual Data
Research & Development
DHA:AMBEEPHA
18GF Score
Ambee Pharmaceuticals Plc DHA:AMBEEPHA
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambee Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of BDT Mil mean?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a Research & Development of BDT Mil as of . 20. Research and development expense is the total cost for research and development activities. View historical data on Ambee Pharmaceuticals and its competitors.
Is Ambee Pharmaceuticals' Research & Development too high?
Ambee Pharmaceuticals' current Research & Development is BDT Mil. Overall, Ambee Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Ambee Pharmaceuticals' Research & Development compare to IMNPQ?
Ambee Pharmaceuticals' Research & Development of BDT Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ambee Pharmaceuticals and its competitors. Ambee Pharmaceuticals's current Research & Development is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambee Pharmaceuticals stock overvalued right now?
Ambee Pharmaceuticals (DHA:AMBEEPHA) has a current Research & Development of BDT Mil. The current Research & Development is BDT Mil. Ambee Pharmaceuticals' overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ambee Pharmaceuticals (DHA:AMBEEPHA), the current Research & Development is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ambee Pharmaceuticals Business Description

Address 184/1 Tejgaon Industrial Area, Dhaka, BGD, 1208
Ambee Pharmaceuticals Plc formerly Ambee Pharmaceuticals Ltd manufactures a wide range of pharmaceutical products in Bangladesh. It is engaged in the business of manufacturing drugs and medicine and sales. Its products are sold in the form of tablets, capsules, liquids, gels, and injectables.
18GF Score

Get the complete analysis for DHA:AMBEEPHA

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT754.00
Price